Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 2.76 EUR 33.33% Market Closed
Market Cap: 122.6m EUR
Have any thoughts about
Sequana Medical NV?
Write Note

Sequana Medical NV
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sequana Medical NV
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Sequana Medical NV
XBRU:SEQUA
Interest Income Expense
-€3.8m
CAGR 3-Years
-59%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Nyxoah SA
XBRU:NYXH
Interest Income Expense
€1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biocartis Group NV
XBRU:BCART
Interest Income Expense
-€17m
CAGR 3-Years
-16%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Interest Income Expense
-€2.6m
CAGR 3-Years
29%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
No Stocks Found

Sequana Medical NV
Glance View

Market Cap
122.6m EUR
Industry
Health Care

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

SEQUA Intrinsic Value
1.56 EUR
Overvaluation 43%
Intrinsic Value
Price

See Also

What is Sequana Medical NV's Interest Income Expense?
Interest Income Expense
-3.8m EUR

Based on the financial report for Jun 30, 2024, Sequana Medical NV's Interest Income Expense amounts to -3.8m EUR.

What is Sequana Medical NV's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-20%

Over the last year, the Interest Income Expense growth was -115%. The average annual Interest Income Expense growth rates for Sequana Medical NV have been -59% over the past three years , -20% over the past five years .

Back to Top